Thousand Oaks Biologics is singularly focused on advancing the art and science of biopharmaceutical process technology development, clinical batch production, and commercial-scale Contract Development and Manufacturing Organization (CDMO) services.

The company has amassed a wealth of expertise in process engineering and production for a diverse array of therapies, including monoclonal antibodies, bispecific antibodies, Antibody-Drug Conjugates (ADCs), fusion proteins, and adenoviral vaccines.

Pioneering a new frontier in the industry's operating model, Thousand Oaks Biologics has seamlessly integrated "JSBio", a leading serum-free cell culture medium brand, into its portfolio. This enables the provision of cutting-edge, chemically-defined, serum-free, and personalized cell culture media, offering a complete package of formulation development, contract manufacturing, and complementary services to the biopharmaceutical sector.

As a provider of end-to-end solutions, ranging from core raw materials to comprehensive Chemistry, Manufacturing, and Controls (CMC) services, Thousand Oaks Biologics embodies a reliable and resourceful partner for biopharmaceutical entities around the globe. The company is renowned for delivering streamlined, high-performance services that underpin the success of biopharmaceutical ventures worldwide.